For: |
Ding Y, Le XP, Zhang QX, Du P. Methylation and mutation analysis of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i3/423.htm |
Number | Citing Articles |
1 |
Takuma Ohashi, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Taisuke Imamura, Jun Kiuchi, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma. British Journal of Cancer 2017; 116(2): 218 doi: 10.1038/bjc.2016.394
|
2 |
Lars Lohne Eftang, Jovana Klajic, Vessela N. Kristensen, Jörg Tost, Qin Ying Esbensen, Gustav Peter Blom, Ida Rashida Khan Bukholm, Geir Bukholm. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2247-8
|
3 |
Shingo Niimi, Mizuho Harashima, Masashi Hyuga, Teruhide Yamaguchi. Study of hepatocytes using RNA interference. Journal of Organ Dysfunction 2007; 3(3): 164 doi: 10.1080/17471060701286559
|
4 |
Takuma Tsuchiya, Liyun Wang, Atsunori Yafune, Masayuki Kimura, Takumi Ohishi, Kazuhiko Suzuki, Kunitoshi Mitsumori, Makoto Shibutani. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16Ink4a) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats. Toxicology 2012; 299(2-3): 146 doi: 10.1016/j.tox.2012.05.018
|
5 |
Yiping Qu, Siwen Dang, Peng Hou. Gene methylation in gastric cancer. Clinica Chimica Acta 2013; 424: 53 doi: 10.1016/j.cca.2013.05.002
|
6 |
Taisuke Imamura, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Jun Kiuchi, Keiji Nishibeppu, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji. Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma. Carcinogenesis 2018; 39(2): 263 doi: 10.1093/carcin/bgx139
|
7 |
T. Y. Kim, H.‐S. Jong, Y. Jung, T.‐Y. Kim, G. H. Kang, Y.‐J. Bang. DNA hypermethylation in gastric cancer. Alimentary Pharmacology & Therapeutics 2004; 20(s1): 131 doi: 10.1111/j.1365-2036.2004.01984.x
|
8 |
Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi, Jun Kiuchi, Hajime Kamiya, Hiroki Shimizu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Takeshi Kubota, Kazuma Okamoto, Hitoshi Fujiwara, Hitoshi Tsuda, Eigo Otsuji. Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer. Cancer Science 2022; 113(6): 1984 doi: 10.1111/cas.15342
|
9 |
M.A. Hayat. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas 2005; 4: 91 doi: 10.1016/S1874-5784(05)80063-7
|
10 |
Jia-Ren Liu, Bing-Qing Chen, Bao-Feng Yang, Hong-Wei Dong, Chang-Hao Sun, Qi Wang, Guo Song, You-Qiang Song. Apoptosis of human gastric adenocarcinoma cells induced by β-ionone. World Journal of Gastroenterology 2004; 10(3): 348-351 doi: 10.3748/wjg.v10.i3.348
|
11 |
Zhengrong Wu, Lirong Wu, Desheng Weng, Dazhi Xu, Jian Geng, Fei Zhao. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. Journal of Experimental & Clinical Cancer Research 2009; 28(1) doi: 10.1186/1756-9966-28-8
|
12 |
E.M. Lima, M.F. Leal, R.R. Burbano, A.S. Khayat, P.P. Assumpção, M.J. Bello, J.A. Rey, M.A.C. Smith, C. Casartelli. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Brazilian Journal of Medical and Biological Research 2008; 41(6): 539 doi: 10.1590/S0100-879X2008000600017
|
13 |
Toshikazu Ushijima, Mitsuru Sasako. Focus on gastric cancer. Cancer Cell 2004; 5(2): 121 doi: 10.1016/S1535-6108(04)00033-9
|
14 |
Y Nishimura, S Komatsu, D Ichikawa, H Nagata, S Hirajima, H Takeshita, T Kawaguchi, T Arita, H Konishi, K Kashimoto, A Shiozaki, H Fujiwara, K Okamoto, H Tsuda, E Otsuji. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. British Journal of Cancer 2013; 108(6): 1324 doi: 10.1038/bjc.2013.65
|
15 |
S Komatsu, D Ichikawa, S Hirajima, H Nagata, Y Nishimura, T Kawaguchi, M Miyamae, W Okajima, T Ohashi, H Konishi, A Shiozaki, H Fujiwara, K Okamoto, H Tsuda, I Imoto, J Inazawa, E Otsuji. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer. British Journal of Cancer 2015; 112(2): 357 doi: 10.1038/bjc.2014.543
|
16 |
Yuying Dong, Jie Wang, Fusheng Dong, Xu Wang, Yinghuai Zhang. The correlations between alteration of p16 gene and clinicopathological factors and prognosis in squamous cell carcinomas of the buccal mucosa. Journal of Oral Pathology & Medicine 2012; 41(6): 463 doi: 10.1111/j.1600-0714.2012.01132.x
|
17 |
Xiao-Mou Peng, Xue-Juan Chen, Jian-Guo Li, Lin Gu, Yang-Su Huang, Zhi-Liang Gao. Novel assay of competitively differentiated polymerase chain reaction for screening point mutation of hepatitis B virus. World Journal of Gastroenterology 2003; 9(8): 1743-1746 doi: 10.3748/wjg.v9.i8.1743
|
18 |
MARKÊNIA KÉLIA SANTOS ALVES, VALESKA PORTELA LIMA, ADRIANA CAMARGO FERRASI, MARIA APARECIDA RODRIGUES, MARIA INÊS DE MOURA CAMPOS PARDINI, SILVIA HELENA BAREM RABENHORST. CDKN2A promoter methylation is related to the tumor location and histological subtype and associated with Helicobacter pylori flaA(+) strains in gastric adenocarcinomas. APMIS 2010; 118(4): 297 doi: 10.1111/j.1600-0463.2010.02591.x
|
19 |
Shuhei Komatsu, Eigo Otsuji. Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan. Annals of Gastroenterological Surgery 2019; 3(6): 581 doi: 10.1002/ags3.12284
|
20 |
Michael Stock, Florian Otto. Gene deregulation in gastric cancer. Gene 2005; 360(1): 1 doi: 10.1016/j.gene.2005.06.026
|
21 |
Jeong Goo Kim, Hideyuki Takeshima, Tohru Niwa, Emil Rehnberg, Yasuyuki Shigematsu, Yukie Yoda, Satoshi Yamashita, Ryoji Kushima, Takao Maekita, Masao Ichinose, Hitoshi Katai, Won Sang Park, Young Seon Hong, Cho Hyun Park, Toshikazu Ushijima. Comprehensive DNA methylation and extensive mutation analyses reveal an association between the CpG island methylator phenotype and oncogenic mutations in gastric cancers. Cancer Letters 2013; 330(1): 33 doi: 10.1016/j.canlet.2012.11.022
|
22 |
Marjan Askari, Ranbir Chander Sobti, Mohsen Nikbakht, Suresh C. Sharma. Promoter hypermethylation of tumour suppressor genes (p14/ARF and p16/INK4a): case–control study in North Indian population. Molecular Biology Reports 2013; 40(8): 4921 doi: 10.1007/s11033-013-2592-5
|
23 |
Fumiaki Sato, Stephen J. Meltzer. CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006; 106(3): 483 doi: 10.1002/cncr.21657
|
24 |
Mohammad Reza Abbaszadegan, Omeed Moaven, Hamid Reza Sima, Kamran Ghafarzadegan, Azadeh A'rabi, Mohammad Naser Forghani, Hamid Reza Raziee, Ali Mashhadinejad, Mostafa Jafarzadeh, Ehsan Esmaili-Shandiz, Ezzat Dadkhah. <italic>p16</italic> promoter hypermethylation: A useful serum marker for early detection of gastric cancer. World Journal of Gastroenterology 2008; 14(13): 2055-2060 doi: 10.3748/wjg.14.2055
|
25 |
Dorra Ben Ayed‐Guerfali, Khemais Benhaj, Abdelmajid Khabir, Mohamed Abid, Mohamed Issam Bayrouti, Tahia Sellami‐Boudawara, Ali Gargouri, Raja Mokdad‐Gargouri. Hypermethylation of tumor‐related genes in tunisian patients with gastric carcinoma: Clinical and biological significance. Journal of Surgical Oncology 2011; 103(7): 687 doi: 10.1002/jso.21875
|
26 |
沛 郭. Clinical Study of Serological Detection in Patients with Gastric Cancer. Medical Diagnosis 2022; 12(02): 201 doi: 10.12677/MD.2022.122032
|
27 |
Kingo Kashimoto, Shuhei Komatsu, Daisuke Ichikawa, Tomohiro Arita, Hirotaka Konishi, Hiroaki Nagata, Hiroki Takeshita, Yukihisa Nishimura, Shoji Hirajima, Tsutomu Kawaguchi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Science 2012; 103(11): 2021 doi: 10.1111/j.1349-7006.2012.02407.x
|
28 |
Hiroki Kobayashi, Shuhei Komatsu, Daisuke Ichikawa, Tsutomu Kawaguchi, Shoji Hirajima, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Toshiyuki Kosuga, Hirotaka Konishi, Atsushi Shiozaki, Hitoshi Fujiwara, Kazuma Okamoto, Hitoshi Tsuda, Eigo Otsuji. Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma. Oncotarget 2015; 6(34): 36615 doi: 10.18632/oncotarget.5620
|
29 |
Maria D. Begnami, José Humberto T.G. Fregnani, Suely Nonogaki, Fernando A. Soares. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Human Pathology 2010; 41(8): 1120 doi: 10.1016/j.humpath.2010.01.007
|
30 |
Zahra Heidari, Hamidreza Mahmoudzadeh Sagheb, Enam Alhagh Charkhat Gorgich. Immunohistochemical Expression of P16ink4a in Colorectal Adenocarcinoma Compared to Adenomatous and Normal Tissue Samples: A Study on Southeast Iranian Samples. Iranian Red Crescent Medical Journal 2017; 19(6) doi: 10.5812/ircmj.15174
|
31 |
Hilal A. Wani, Sabhiya Majid, Arif A. Bhat, Shajrul Amin, Rabia Farooq, Showkat A. Bhat, Nissar A. Naikoo, Mushtaq A. Beigh, Showkat A. Kadla. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer. European Journal of Cancer Prevention 2019; 28(2): 68 doi: 10.1097/CEJ.0000000000000485
|
32 |
Luigi Wolkmer Spagnol, Jossimara Polettini, Daniela Augustin Silveira, Gustavo Roberto Minetto Wegner, Daniel Felipe Fernandes Paiva. P16 gene promoter methylation is associated with oncogenesis and progression of gastric carcinomas: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2022; 180: 103843 doi: 10.1016/j.critrevonc.2022.103843
|